[Isolated lung transplantation].
Over the last 10 years, single and bilateral lung transplantation has developed from an experimental technique to a valid therapy for patients with end-stage pulmonary or pulmonary-vascular disease. The main reasons for this progress are better defined selection criteria, improved operative technique and organ preservation, optimized peri- and postoperative management and more precise immunosuppressive and antiinfective therapy. Since 1983 more than 3000 lung transplantations have been performed worldwide with a 1- and 3-year survival rate of 70-90% and 60-70% respectively. In Switzerland 41 lung transplantations have been performed since 1992 with a 1-year survival rate of more than 80%. Indications, technique, treatment and results are discussed.
Weder
W
W
Departement Chirurgie, Universitätsspital Zürich.
Speich
R
R
Boehler
A
A
Zollinger
A
A
Stocker
R
R
Lang
T
T
Largiadèr
F
F
D000328:Adult; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000601:surgery; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008173:Lung Diseases, Obstructive / Q000601:surgery; D016040:Lung Transplantation / Q000379:methods* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000517:prevention & control; D011182:Postoperative Care; D012648:Self Care; D015996:Survival Rate
D007166:Immunosuppressive Agents
Die isolierte Lungentransplantation.